Overview

A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease

Status:
Completed

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

This study investigates safety and efficacy of CP-690,550 in adult patients with moderate to severe Crohn's disease. The study hypothesis is that at least one dose of the tested drug is more effective than placebo (inactive drug).

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Tofacitinib